Pfizer Inc. (VIE:PFE)

Austria flag Austria · Delayed Price · Currency is EUR
22.28
+0.37 (1.67%)
At close: Dec 5, 2025
-9.41%
Market Cap 125.30B
Revenue (ttm) 53.69B
Net Income (ttm) 8.41B
Shares Out n/a
EPS (ttm) 1.48
PE Ratio 14.91
Forward PE 8.62
Dividend 1.53 (6.99%)
Ex-Dividend Date Nov 7, 2025
Volume 806
Average Volume 957
Open 22.00
Previous Close 21.92
Day's Range 22.00 - 22.29
52-Week Range 18.70 - 26.50
Beta n/a
RSI 52.54
Earnings Date Feb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Industry Pharmaceutical Preparations
Founded 1849
Employees 81,000
Stock Exchange Vienna Stock Exchange
Ticker Symbol PFE
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements

News

There is no news available yet.